Dana Farber Cancer Institute
Boston, Massachusetts, 02215, United States
NCT Number: NCT03913936
This research study is piloting a new internet-based research tool (YES portal). The main purpose of this pilot study is to test the web-based interface.
Looking for future studies?
Notify Me18 year–44 year
Female
Interventional
Not applicable
Boston, Massachusetts, 02215, United States
This study is being done to pilot a web-based research intervention tool. The investigators hope that by piloting it with the participants they can improve the tool and the other processes. The main purpose of this pilot study is to test the web-based interface, the participant's engagement with the platform, and the recruitment procedures. This initial pilot study will inform the design of a larger study intended to monitor common symptoms and behavior, and to provide supportive care information and research opportunities in an iterative manner for young women who have been diagnosed with breast cancer using the YES portal, built for smartphones, tablets, and computers.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
N/A
The YES portal is designed to collect and assess participants' toxicities and symptoms, as well as informational needs in between visits with their clinician
Time frame: 2 years
To measure the number of times participants engage with the portal using log in data collected from back-end of portal.
Time frame: 2 years
To summarize the number of hours/minutes the participant spent using portal through data collected from back-end of portal.
Time frame: 2 years
To summarize the number of hours/minutes the survey takes to complete through data collected from back-end of portal.
Time frame: 2 years
To measure the number of times participants download the resource sources provided through data collected from back-end of portal.
Time frame: 2 years
Investigator developed questions will be used to assess the utility of the portal including the perceived usefulness of portal in addressing symptoms and needs and ease of use.
Time frame: 2 years
Investigator developed questions asking participants for feedback pertaining to ways to improve the portal and processes.
Dana-Farber Cancer Institute
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06068257
Breast Cancer, Breast Diseases
Orlando, Florida, United States
View Trial DetailsNCT05754658
Breast Cancer, Breast Diseases
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT07040514
Breast Cancer, Breast Diseases
Lebanon, New Hampshire, United States
View Trial DetailsNCT06604858
Breast Cancer, Breast Diseases
A Coruña, Spain
View Trial Details